Literature DB >> 28360393

Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome.

Maheswari Thangavelu1, Usha Rani Godla, F D Paul Solomon, Ravi Maddaly.   

Abstract

Polycystic ovary syndrome (PCOS) is the most common and a complex female endocrine disorder, and is one of the leading cause of female infertility. Here, we aimed to investigate the association of single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 gene in the pathogenesis of PCOS. A hospital-based, observational case-control study was carried on 169 PCOS and 169 control women in the southern region of India. Genotype was carried out by real-time polymerase chain reaction. A chi-square (χ2) test was performed and the genotypes were verified to comply with the Hardy- Weinberg equilibrium. Odds ratio and 95% confidence interval were calculated to assess the relative risk. Comparison of clinical characteristics of women with PCOS and controls reveal an increase in body mass index (BMI), luteinizing hormone / follicle stimulating hormone (LH/FSH) ratio, glucose levels, insulin, testosterone, hirsutism and antral follicular count in PCOS women. The variant rs1801278 (P = 0.002; OR = 2.88; 95% CI = 1.43, 5.80) show an association with PCOS. In the genotypic (P = 0.0002) and allelic models (P = 0.000), significance persisted even after Bonferroni correction. The genotypes of SNPs strongly influence BMI, LH, LH/FSH ratio, ovarian volume and antral follicular count in PCOS women. The study results were suggestive of a positive association between Gly972Arg of IRS1 and PCOS in the south Indian population, while INS, IRS2, PPAR-G and CAPN10 failed to show any association with PCOS in our studied population. Further studies focussing the role of IRS1 are warranted to delineate its implication towards PCOS.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28360393     DOI: 10.1007/s12041-017-0749-z

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  49 in total

1.  The INS 5' variable number of tandem repeats is associated with IGF2 expression in humans.

Authors:  J Paquette; N Giannoukakis; C Polychronakos; P Vafiadis; C Deal
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

2.  Association of Gly972Arg variant of insulin receptor substrate-1 with metabolic features in women with polycystic ovary syndrome.

Authors:  Saffet Dilek; Devrim Ertunc; Ekrem C Tok; Emin M Erdal; Atil Aktas
Journal:  Fertil Steril       Date:  2005-08       Impact factor: 7.329

3.  Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome.

Authors:  D M Waterworth; S T Bennett; N Gharani; M I McCarthy; S Hague; S Batty; G S Conway; D White; J A Todd; S Franks; R Williamson
Journal:  Lancet       Date:  1997-04-05       Impact factor: 79.321

4.  Expression of insulin-receptor substrate-1 and -2 in ovaries from women with insulin resistance and from controls.

Authors:  X Wu; K Sallinen; L Anttila; M Mäkinen; C Luo; P Pöllänen; R Erkkola
Journal:  Fertil Steril       Date:  2000-09       Impact factor: 7.329

5.  Peroxisome proliferator activated receptor gamma gene variants influence susceptibility and insulin related traits in Indian women with polycystic ovary syndrome.

Authors:  Nuzhat Shaikh; Ankur Mukherjee; Nalini Shah; Pervin Meherji; Srabani Mukherjee
Journal:  J Assist Reprod Genet       Date:  2013-06-09       Impact factor: 3.412

6.  A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance.

Authors:  L J Baier; P A Permana; X Yang; R E Pratley; R L Hanson; G Q Shen; D Mott; W C Knowler; N J Cox; Y Horikawa; N Oda; G I Bell; C Bogardus
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

7.  Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome.

Authors:  David A Ehrmann; Xu Tang; Issei Yoshiuchi; Nancy J Cox; Graeme I Bell
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

8.  Association between the Pro12Ala polymorphism of PPAR-γ gene and the polycystic ovary syndrome: a meta-analysis of case-control studies.

Authors:  Hong Zhang; Yan Bi; Changjun Hu; Weiping Lu; Dalong Zhu
Journal:  Gene       Date:  2012-05-04       Impact factor: 3.688

Review 9.  Mutations in insulin-receptor gene in insulin-resistant patients.

Authors:  S I Taylor; T Kadowaki; H Kadowaki; D Accili; A Cama; C McKeon
Journal:  Diabetes Care       Date:  1990-03       Impact factor: 19.112

10.  No association of the insulin gene VNTR polymorphism with polycystic ovary syndrome in a Han Chinese population.

Authors:  Yuping Xu; Zhaolian Wei; Zhiguo Zhang; Qiong Xing; Pin Hu; Xiaohui Zhang; Guihua Gao; Yong Wang; Qian Gao; Long Yi; Yunxia Cao
Journal:  Reprod Biol Endocrinol       Date:  2009-12-01       Impact factor: 5.211

View more
  10 in total

Review 1.  Multiomics Analysis-Based Biomarkers in Diagnosis of Polycystic Ovary Syndrome.

Authors:  Shikha Rani; Piyush Chandna
Journal:  Reprod Sci       Date:  2022-01-27       Impact factor: 3.060

2.  Mutational Landscape Screening Through Comprehensive In Silico Analysis for Polycystic Ovarian Syndrome-Related Genes.

Authors:  Shrinjana Dhar; Saptarshi Mridha; Pritha Bhattacharjee
Journal:  Reprod Sci       Date:  2021-10-25       Impact factor: 3.060

3.  Variant Alleles of the ESR1, PPARG, HMGA2, and MTHFR Genes Are Associated With Polycystic Ovary Syndrome Risk in a Chinese Population: A Case-Control Study.

Authors:  Xianting Jiao; Weiwei Chen; Jun Zhang; Weiye Wang; Junjiao Song; Dan Chen; Wenting Zhu; Yuhua Shi; Xiaodan Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-30       Impact factor: 5.555

4.  The Association Between the rs2975760 and rs3792267 Single Nucleotide Polymorphisms of Calpain 10 (CAPN10) and Gestational Diabetes Mellitus.

Authors:  Xia Zhang; Chunhong Shi; Lili Wei; Fengyun Sun; Li Ji
Journal:  Med Sci Monit       Date:  2019-07-11

5.  Peroxisome Proliferator-Activated Receptor Gamma Modulator Promotes Neonatal Mouse Primordial Follicle Activation In Vitro.

Authors:  Sook Young Yoon; Ran Kim; Hyunmee Jang; Dong Hyuk Shin; Jin Il Lee; Dongwon Seol; Dong Ryul Lee; Eun Mi Chang; Woo Sik Lee
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

6.  Clinical Manifestations of Hyperandrogenism and Ovulatory Dysfunction Are Not Associated with His1058 C/T SNP (rs1799817) Polymorphism of Insulin Receptor Gene Tyrosine Kinase Domain in Kashmiri Women with PCOS.

Authors:  Shayaq Ul Abeer Rasool; Sairish Ashraf; Mudasar Nabi; Shariq R Masoodi; Khalid M Fazili; Shajrul Amin
Journal:  Int J Endocrinol       Date:  2021-12-06       Impact factor: 3.257

7.  Insulin Receptor Substrate 1 Gly972Arg (rs1801278) Polymorphism Is Associated with Obesity and Insulin Resistance in Kashmiri Women with Polycystic Ovary Syndrome.

Authors:  Shayaq Ul Abeer Rasool; Mudasar Nabi; Sairish Ashraf; Shajrul Amin
Journal:  Genes (Basel)       Date:  2022-08-17       Impact factor: 4.141

Review 8.  An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options.

Authors:  Hiya Islam; Jaasia Masud; Yushe Nazrul Islam; Fahim Kabir Monjurul Haque
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

9.  The role of AKT and FOXO3 in preventing ovarian toxicity induced by cyclophosphamide.

Authors:  Bao-Fang Zhang; YaXin Hu; Xinyan Liu; Zhuo Cheng; Yu Lei; YongMei Liu; Xueke Zhao; Mao Mu; Lei Yu; Ming-Liang Cheng
Journal:  PLoS One       Date:  2018-08-02       Impact factor: 3.240

Review 10.  Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India.

Authors:  Mohammad Ashraf Ganie; Vishnu Vasudevan; Imtiyaz Ahmad Wani; Mohammad Salem Baba; Tasleem Arif; Aafia Rashid
Journal:  Indian J Med Res       Date:  2019-10       Impact factor: 2.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.